Name of License: US Biologic, Inc.
Summary: Notice is hereby given that the U.S. Department of Agriculture, Agricultural Research Service, intends to grant to US Biologic, Inc. of Memphis, Tennessee, an exclusive license to the Federal Government’s rights in U.S. Provisional Patent Application Serial No. 63/040,718, “COMPOSITION AND METHOD OF AN ORALLY ADMINISTERED ANTIMICROBIAL PEPTIDE VECTORED IN A BACTERIAL EXPRESSION VEHICLE,” filed on June 18, 2020.
Tech Name:
ORALLY ADMINISTERED ANTIMICROBIAL
Dates: Comments must be received on or before February 11, 2021.
Address: Send comments to: Diana D. Halsey, Acting Business Licensing Officer, USDA, ARS, Office of Technology Transfer, 301-504-4878, [email protected].
For Further Information Contact: Diana D. Halsey, Acting Business Licensing Officer, USDA, ARS, Office of Technology Transfer, 301-504-4878, [email protected].
Supplementary Information: The patent rights in this invention are co-owned by the United States of America, as represented by the Secretary of Agriculture, and US Biologic, Inc. of Memphis, Tennessee. The prospective exclusive license will grant to the co-owner, US Biologic, Inc., an exclusive license to the Federal Government’s patent rights. It is in the public interest to so license this invention as US Biologic, Inc. of Memphis, Tennessee has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within thirty (30) days from the date of this published Notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.